Reduction in Mortality from Breast Cancer

Overview

Journal BMJ

Specialty General Medicine

Date 2005 Jan 29

PMID 15677633

Citations 4

Authors

Alison L Jones

Affiliations

Soon will be listed here.

Citing Articles

Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.

Steponaviciene L, Briediene R, Vanseviciute R, Smailyte G Cancer Control. 2019; 26(1):1073274818821096.

PMID: 30808202 PMC: 6327347. DOI: 10.1177/1073274818821096.

Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.

Autier P, Boniol M, Gavin A, Vatten L BMJ. 2011; 343:d4411.

PMID: 21798968 PMC: 3145837. DOI: 10.1136/bmj.d4411.

An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.

Pachmann K, Dengler R, Lobodasch K, Frohlich F, Kroll T, Rengsberger M J Cancer Res Clin Oncol. 2007; 134(1):59-65.

PMID: 17611779 DOI: 10.1007/s00432-007-0248-3.

Reduction in mortality from breast cancer: reasons for improved survival are more complex than suggested.

Morgan G BMJ. 2005; 330(7498):1025.

PMID: 15860838 PMC: 557186. DOI: 10.1136/bmj.330.7498.1025-a.

References

Sant M, Allemani C, Berrino F, Coleman M, Aareleid T, Chaplain G . Breast carcinoma survival in Europe and the United States. Cancer. 2004; 100(4):715-22. DOI: 10.1002/cncr.20038. View

Bonadonna G, Moliterni A, Zambetti M, Daidone M, Pilotti S, Gianni L . 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ. 2005; 330(7485):217. PMC: 546063. DOI: 10.1136/bmj.38314.622095.8F. View

Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes J . Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet. 2005; 365(9453):60-2. DOI: 10.1016/S0140-6736(04)17666-6. View

Blanks R, Moss S, McGahan C, Quinn M, Babb P . Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ. 2000; 321(7262):665-9. PMC: 27479. DOI: 10.1136/bmj.321.7262.665. View

van de Vijver M, He Y, Vant Veer L, Dai H, Hart A, Voskuil D . A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002; 347(25):1999-2009. DOI: 10.1056/NEJMoa021967. View

Sotiriou C, Neo S, McShane L, Korn E, Long P, Jazaeri A . Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003; 100(18):10393-8. PMC: 193572. DOI: 10.1073/pnas.1732912100. View

Goss P, Ingle J, Martino S, Robert N, Muss H, Piccart M . A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med. 2003; 349(19):1793-802. DOI: 10.1056/NEJMoa032312. View

Olsen A, Njor S, Vejborg I, Schwartz W, Dalgaard P, Jensen M . Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005; 330(7485):220. PMC: 546064. DOI: 10.1136/bmj.38313.639236.82. View

Coombes R, Hall E, Gibson L, Paridaens R, Jassem J, Delozier T . A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med. 2004; 350(11):1081-92. DOI: 10.1056/NEJMoa040331. View

10.

Hebert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G . Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol. 2004; 22(18):3685-93. DOI: 10.1200/JCO.2004.07.018. View

11.

. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998; 352(9132):930-42. View

12.

Sainsbury R, Johnston C, Haward B . Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet. 1999; 353(9159):1132-5. DOI: 10.1016/s0140-6736(99)02374-0. View